Authors:
Asahara, T
Masuda, H
Takahashi, T
Kalka, C
Pastore, C
Silver, M
Kearne, M
Magner, M
Isner, JM
Citation: T. Asahara et al., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, CIRCUL RES, 85(3), 1999, pp. 221-228
Authors:
Couffinhal, T
Silver, M
Kearney, M
Sullivan, A
Witzenbichler, B
Magner, M
Annex, B
Peters, K
Isner, JM
Citation: T. Couffinhal et al., Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE(-/-) mice, CIRCULATION, 99(24), 1999, pp. 3188-3198
Authors:
Fabre, JE
Rivard, A
Magner, M
Silver, M
Isner, JM
Citation: Je. Fabre et al., Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo, CIRCULATION, 99(23), 1999, pp. 3043-3049
Authors:
Chen, DH
Asahara, T
Krasinski, K
Witzenbichler, B
Yang, JH
Magner, M
Kearney, M
Frazier, WA
Isner, JM
Andres, V
Citation: Dh. Chen et al., Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery, CIRCULATION, 100(8), 1999, pp. 849-854
Authors:
Symes, JF
Losordo, DW
Vale, PR
Lathi, KG
Esakof, DD
Mayskiy, M
Isner, JM
Citation: Jf. Symes et al., Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease, ANN THORAC, 68(3), 1999, pp. 830-836
Authors:
Rivard, A
Silver, M
Chen, DF
Kearney, M
Magner, M
Annex, B
Peters, K
Isner, JM
Citation: A. Rivard et al., Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF, AM J PATH, 154(2), 1999, pp. 355-363
Authors:
van der Zee, R
Murohara, T
Passeri, J
Kearney, M
Cheresh, DA
Isner, JM
Citation: R. Van Der Zee et al., Reduced intimal thickening following alpha v beta 3 blockade is associatedwith smooth muscle cell apoptosis, CELL AD COM, 6(5), 1998, pp. 371
Authors:
Isner, JM
Baumgartner, I
Rauh, G
Schainfeld, R
Blair, R
Manor, O
Razvi, S
Symes, JF
Citation: Jm. Isner et al., Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results, J VASC SURG, 28(6), 1998, pp. 964-973
Authors:
Losordo, DW
Vale, PR
Symes, JF
Dunnington, CH
Esakof, DD
Maysky, M
Ashare, AB
Lathi, K
Isner, JM
Citation: Dw. Losordo et al., Gene therapy for myocardial angiogenesis - Initial clinical results with direct myocardial injection of phVEGF(165) as sole therapy for myocardial ischemia, CIRCULATION, 98(25), 1998, pp. 2800-2804
Authors:
Spyridopoulos, I
Principe, N
Krasinski, KL
Xu, SH
Kearney, M
Magner, M
Isner, JM
Losordo, DW
Citation: I. Spyridopoulos et al., Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis, CIRCULATION, 98(25), 1998, pp. 2883-2890
Citation: Jm. Isner, Vascular endothelial growth factor: Gene therapy and therapeutic angiogenesis - Questions and answers, AM J CARD, 82(10A), 1998, pp. 64S-64S